WebMay 10, 2024 · Dhan Chand. As you are aware, Agenus is well familiar with the LT space. In fact, we built Merck ILT4 antibody MK-4830, which is progressing in the clinic, showing activity in patients that are ... WebApr 6, 2024 · Dr. Jennifer Buell and Dr. Dhan Chand will also be available to discuss the Fc-engineering driving AGEN1181’s enhanced activity, and how the AACR presentations support AGEN1181’s place in the ...
Dhan CHAND Senior Scientist PhD Agenus, MA
WebAug 6, 2024 · Dhan Chand Thank you, Jen. While PD-1 and PDL-1 antibodies have been a spectacular commercial success, only a small portion of patients have had sustainable … WebSenior Scientific Director, Head of Drug Discovery, Agenus Inc. - Cited by 414 - Cancer Immunology - Cell and Molecular Biology - Neuroscience - Endocrinology ... Dhan Chand. Senior Scientific Director, Head of Drug Discovery, Agenus … grading wheat
Dhan Chand - Vice President, Research
WebMay 11, 2024 · Welcome to Agenus first quarter 2024 financial results conference call. My name is James and I'll be your operator for today's call. ... Dhan Chand-- Scientific Director and Head of Drug Discovery ... WebSep 27, 2024 · View Dhan Chand's email address (d*****@agenus***.com) and phone number. Dhan works at Agenus as Scientific Director, Head of Drug Discovery. Dhan is based out of Lexington, Massachusetts, United States and works in the Biotechnology Research industry. WebNov 13, 2024 · Dr. Jennifer Buell and Dr. Dhan Chand of Agenus will be available to discuss the next steps for AGEN1181 and indications selected for expansion. grading vs staging cancer